JP Morgan Chase’s FT Vest US Equity Enhance & Moderate Buffer ETF December XDEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117K Buy
2,745
+1,103
+67% +$46.5K ﹤0.01% 5929
2026
Q1
$65.2K Sell
1,642
-793
-33% -$32.5K ﹤0.01% 6068
2025
Q4
$99.7K Buy
2,435
+1,953
+405% +$79.1K ﹤0.01% 5898
2025
Q3
$19.3K Sell
482
-294
-38% -$11.6K ﹤0.01% 6484
2025
Q2
$30.1K Hold
776
﹤0.01% 6071
2025
Q1
$28.6K Hold
776
﹤0.01% 6045
2024
Q4
$28.9K Buy
+776
New +$28.8K ﹤0.01% 6164
2023
Q3
Sell
-9,263
Closed -$302K 7765
2023
Q2
$302K Sell
9,263
-84
-0.9% -$2.67K ﹤0.01% 4821
2023
Q1
$292K Buy
+9,347
New +$286K ﹤0.01% 4825

Other funds holding XDEC

JP Morgan Chase's XDEC Position: Q2 2026 in Review

JP Morgan Chase increased its FT Vest US Equity Enhance & Moderate Buffer ETF December (XDEC) stake by 67% in Q2 2026, buying an estimated $46.5K and bringing the position to 2,745 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #5929.

JP Morgan Chase first reported a position in XDEC in Q1 2023 and has held it in 9 quarters since. The position peaked at $302K in Q2 2023. 84 funds tracked by Wall St. Rank hold XDEC as of Q2 2026.

  • JP Morgan Chase held 2,745 shares of FT Vest US Equity Enhance & Moderate Buffer ETF December worth $117K as of Q2 2026.
  • JP Morgan Chase bought 1,103 FT Vest US Equity Enhance & Moderate Buffer ETF December shares in Q2 2026, an estimated $46.5K.
  • FT Vest US Equity Enhance & Moderate Buffer ETF December made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5929 holding.
  • JP Morgan Chase first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF December in Q1 2023 and has held it in 9 quarters since.
  • JP Morgan Chase's FT Vest US Equity Enhance & Moderate Buffer ETF December position peaked at $302K in Q2 2023.
  • 84 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF December as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.